Understanding Preeclampsia: Definitions and Classifications
Preeclampsia is a hypertensive disorder occurring after 20 weeks of gestation. It requires systolic blood pressure of 140 mmHg or higher and/or diastolic blood pressure of 90 mmHg or higher on two separate occasions at least 4 hours apart. Additionally, preeclampsia requires proteinuria (300 mg or more per 24-hour urine collection or 1+ on dipstick) or other signs of end-organ dysfunction.
Two Classification Categories
The condition divides into two categories based on severity. Preeclampsia without severe features presents with mild hypertension and proteinuria. Preeclampsia with severe features includes systolic BP 160 mmHg or higher, diastolic BP 110 mmHg or higher, platelet count less than 100,000, doubled serum creatinine, pulmonary edema, cerebral or visual symptoms, and elevated liver enzymes.
Eclampsia and HELLP Syndrome
Eclampsia is the development of seizures in a patient with preeclampsia that cannot be attributed to other causes. HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) is a severe variant featuring hemolytic anemia, thrombocytopenia, and hepatic dysfunction.
Understanding these distinctions is critical because management strategies differ significantly based on severity classification and presence of severe features.
Risk Factors and Pathophysiology in Nursing Assessment
Multiple factors increase preeclampsia risk, and nurses must identify patients requiring closer monitoring. Major risk factors include first pregnancy, maternal age over 35 years, obesity, chronic hypertension, diabetes mellitus, chronic kidney disease, and autoimmune disorders.
Patients with previous preeclampsia have significantly higher recurrence rates. Multiple gestations, molar pregnancy, and thrombophilias also increase risk.
Understanding Abnormal Placentation
The pathophysiology involves abnormal placentation and endothelial dysfunction. In normal pregnancy, trophoblastic invasion remodels spiral arteries, reducing vascular resistance. In preeclampsia, inadequate trophoblastic invasion prevents proper arterial remodeling.
This maintains high vascular resistance and reduces placental perfusion. The result is release of placental factors that damage maternal endothelium, increasing vascular permeability and reducing intravascular volume.
Clinical Manifestations Explained
Vasospasm causes hypertension. Glomerular damage causes proteinuria. Platelet consumption causes thrombocytopenia. Hepatic ischemia causes elevated liver enzymes. Nurses use this pathophysiologic understanding to anticipate complications and recognize when patients progress toward eclampsia or HELLP syndrome.
Clinical Assessment and Monitoring Protocols
Comprehensive assessment is fundamental to preeclampsia nursing care. Establish baseline vital signs, then monitor blood pressure consistently using appropriate technique: patient seated with feet flat, arm at heart level, using a cuff of appropriate size. Recheck after rest periods if elevated.
Neurologic and Physical Assessment
Assess for signs of severe features including headache (especially occipital), visual disturbances, epigastric pain, and decreased urine output. Perform thorough neurologic assessments, noting hyperreflexia and ankle clonus, which indicate central nervous system irritability and increased seizure risk. Evaluate edema distribution, recognizing that edema in face, hands, or sacral area may indicate severe disease.
Fluid and Output Monitoring
Monitor urinary output carefully, as oliguria (less than 400-500 mL per 24 hours) suggests renal involvement. Weight gain exceeding 2 pounds per week may indicate fluid retention. Document these findings precisely in your nursing notes.
Laboratory and Fetal Monitoring
Laboratory monitoring includes 24-hour urine protein collection, serum creatinine, liver enzymes, platelet count, and coagulation studies. Fetal assessment includes non-stress testing and biophysical profile to evaluate placental function. Continuous assessment helps distinguish between mild and severe preeclampsia, guides medication administration, and identifies deterioration requiring delivery.
Pharmacological Management and Medication Knowledge
Pharmacologic management depends on preeclampsia severity and gestational age. For severe preeclampsia with severe features, antihypertensive therapy is essential to prevent maternal complications.
First-Line Antihypertensive Agents
Labetalol is a combined alpha-beta blocker given intravenously starting at 20 mg, then 40-80 mg every 10 minutes (maximum 220 mg per episode). Extended-release oral labetalol provides maintenance therapy.
Immediate-release nifedipine (calcium channel blocker) is given orally at 10-20 mg every 20-30 minutes (maximum 160 mg in first hour, then 120 mg daily).
Hydralazine (direct vasodilator) is given intravenously at 5-10 mg every 20 minutes as needed.
Magnesium Sulfate for Seizure Prophylaxis
Magnesium sulfate is administered to prevent seizures in severe preeclampsia. Loading dose is 4-6 grams intravenously over 20-30 minutes, followed by 1-2 grams per hour maintenance. Magnesium is eliminated renally, so renal function monitoring is critical.
Toxicity signs include loss of deep tendon reflexes, respiratory depression, and decreased cardiac output. Maintain careful intake and output records. Keep calcium gluconate (magnesium antidote) readily available. Understanding drug actions, dosing, routes, and adverse effects is essential for safe practice.
Emergency Care: Managing Eclampsia and Complications
Eclampsia management represents a nursing emergency requiring rapid, coordinated intervention. When seizures occur, protect the patient from injury by padding bed rails and positioning side-lying to prevent aspiration. Ensure airway safety above all else.
Remain calm and document seizure characteristics: onset, duration, body parts involved, and consciousness level. After seizure, maintain airway patency, have suction immediately available, and ensure oxygen administration.
Critical Actions
Administer magnesium sulfate as ordered if not already given. Alert the provider immediately and prepare for potential delivery, as definitive treatment for eclampsia is delivery of fetus and placenta.
Monitoring for Complications
Monitor for pulmonary edema, a potentially fatal complication causing dyspnea, crackles, and frothy sputum. Assess for acute coronary syndrome manifestations and stroke symptoms. Manage hypertensive emergencies with rapid-acting agents to prevent intracranial hemorrhage, but avoid excessive blood pressure lowering which can reduce placental perfusion.
Keep family informed and provide emotional support during this frightening situation. Post-eclampsia care includes continued assessment, as preeclampsia with seizures can recur postpartum. Watch for aspiration pneumonia, pulmonary edema, renal failure, and disseminated intravascular coagulation.
